Tapewire

Nasdaq · USD

BCDA

BioCardia, Inc.

Export transactions ↓
Tapewire entity
7752
SEC CIK
0000925741
Parsed reports
349

Last 12 months

Inside the activity.

32 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202520
Jan 202620
Feb 202610
Mar 202620
Apr 202630
May 202640
Jun 202650
Jul 202680
Aug 202620
Sep 202630
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 13, 2017 Filed Jan 18, 2017 23:39 UTC GrantRestricted Stock Units · Derivative 184,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-17-000795 · rdgdoc.xml · derivative · entry 1

KRASNO RICHARD M · CIK 0001215060 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,000

Underlying: Common Stock · 184,000 shares

Expires 2020-01-13

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units vest and become exercisable as to one-third of the shares on January 13, 2018 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Read SEC document
January 13, 2017 Filed Jan 18, 2017 23:39 UTC GrantRestricted Stock Units · Derivative 184,000 $0.00 $0.00
Disclosure

SEC source: 0001437749-17-000793 · rdgdoc.xml · derivative · entry 1

PFENNIGER RICHARD C JR · CIK 0001200796 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,000

Underlying: Common Stock · 184,000 shares

Expires 2020-01-13

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units vest and become exercisable as to one-third of the shares on January 13, 2018 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Read SEC document
January 09, 2017 Filed Jan 10, 2017 22:56 UTC PurchaseCommon Stock 10,000 $0.82 $8,228.00
Disclosure

SEC source: 0001437749-17-000473 · rdgdoc.xml · nonDerivative · entry 1

STERTZER SIMON H · CIK 0001031689 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 31,039,310

F1 · price: This transaction was executed in multiple trades at prices ranging from $0.818 to $0.83 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares purchased at each separate price.

F2 · ownership.nature: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees.

Read SEC document
December 22, 2016 Filed Dec 28, 2016 02:08 UTC PurchaseCommon Stock 72,600 $0.51 $37,026.00
Disclosure

SEC source: 0001437749-16-043819 · rdgdoc.xml · nonDerivative · entry 1

STERTZER SIMON H · CIK 0001031689 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 31,029,310

F1 · ownership.nature: These shares are held by the Stertzer Family Trust, of which the Reporting Person and his spouse are co-trustees.

Read SEC document
December 21, 2016 Filed Dec 23, 2016 11:02 UTC SaleCommon Stock 19,230,769 $0.13 $2,499,999.97
Disclosure

SEC source: 0001437749-16-043713 · rdgdoc.xml · nonDerivative · entry 1

FROST PHILLIP MD ET AL · CIK 0000898860 · 10% owner

Frost Gamma Investments Trust · CIK 0001380896 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 130,503,835

F1 · ownership.nature: These securities are held by Frost Gamma Investments Trust, of which the Reporting Person is the trustee. Frost Gamma Limited Partnership is the sole and exclusive beneficiary of Frost Gamma Investments Trust. The Reporting Person is one of two limited partners of Frost Gamma Limited Partnership. The general partner of Frost Gamma Limited Partnership is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation, of which the Reporting Person is the sole shareholder.

Read SEC document
November 01, 2016 Filed Dec 28, 2016 02:07 UTC PurchaseCommon Stock 100,000 $0.16 $16,410.00
Disclosure

SEC source: 0001437749-16-043818 · rdgdoc.xml · nonDerivative · entry 1

STERTZER SIMON H · CIK 0001031689 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 4,816,171

F1 · price: This transaction was executed in multiple trades at prices ranging from $0.1620 to $0.1650 per share. The price reported above reflects the weighted average per share purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares purchased at each separate price.

F2 · ownership.nature: These shares are held by Windrock Enterprises L.L.C., of which the Reporting Person and his spouse are sole members and managers.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.